Minerva Surgical is a Cupertino-based medical device company that developed an endometrial ablation system using RF argon plasma energy contained in a balloon to treat heavy menstrual bleeding. A recent SEC regulatory filing shows the company raised $20 million in the latest financing. The filing does not specify the instrument or the participating investors for this raise. SEC Edgar records indicate Minerva has been steadily raising capital since 2008 and has raised more than $55 million to date. David M. Clapper, a 16-year veteran of Johnson & Johnson, serves as the company’s CEO. Known backers include New Enterprise Associates and Vivo Ventures, though their participation in this round was not disclosed.

Total raised

$20M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2013